Skip to content
Delayed ~15 min

TVTX TRAVERE THERAPEUTICS

Health Care · Russell 2000

Next earnings: not announced yet

What 15 analyst firms say about TRAVERE THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

49.60 USD+0.73 (+1.49%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+42.0%to the avg target 70.44 USD+20.84 USD
Buy 13 · Hold 0 · Sell 1

14 rated views · 15 analyst/firm records · 15 firms

Latest report4 Nov 2026avg report date 11 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MGood · #76 in the index82
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8073

Recent analyst activity · last 90 days

Our tracked history has 10 reports on TVTX from 9 analyst firms in the last 90 days (15 firms in the past year).

Comparing each firm's latest target with its previous one: 3 raised their price target, 2 lowered it and 1 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: SVB Leerink lowered its target from $78.00 (set 4 Aug 2026) to $67.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Canaccord GenuityEdward NashBuy6 Aug 202670.00 USD
Cantor FitzgeraldPrakhar AgrawalBuy23 Mar 2026—
CitigroupYigal NochomovitzBuy5 Aug 202685.00 USD
Evercore ISIGavin Clark-GartnerBuy5 Aug 2026Conflicting reports · excluded
GuggenheimVamil DivanBuy4 Nov 202678.00 USD
H.C. WainwrightJoseph PantginisBuy22 Sep 202667.00 USD
JefferiesMaury RaycroftBuy5 Aug 202664.00 USD
JPMorganAnupam RamaBuy25 Mar 202641.00 USD
Leerink PartnersJoseph P SchwartzBuy4 Aug 202678.00 USD
Piper SandlerAllison M BratzelBuy17 Aug 2026—
TD CowenTyler Van BurenBuy5 Aug 202675.00 USD
WedbushLaura ChicoBuy22 Sep 202676.00 USD
Weiss RatingsUnnamed analyst—18 Sep 2026—
Wells FargoMohit BansalBuy12 Jun 2026Conflicting reports · excluded
Data feed RESEARCHResearch TeamSell20 Oct 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:38 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.